Clinical Trial Update: A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TAK-861 for narcolepsy with cataplexy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-861

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy | Phase 3 | Status: RECRUITING